The company’s stock has suffered its biggest monthly decline since 2020 as demand wanes for coronavirus products.
US pharmaceutical giant Pfizer released a disappointing earnings report on Tuesday, with a weaker-than-estimated sales outlook for its Covid-19 drugs.
Continue reading https://on.rt.com/c8fc